"Quarterly Financial Report - Confidential"

**Period Ended March 31, 2024**

The Company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) for the quarter is $15.2 million, representing a year-over-year increase of 12% compared to Q1 FY23.

**Key Financial Highlights:**

* Net Revenue: $42.5 million, exceeding our forecast of $40 million by 5%
* Gross Margin: 35.6%, a 150 basis point expansion from the same period last year
* Operating Expenses: $13.8 million, within budget and reflecting our ongoing efforts to optimize cost structure

**Outlook and Strategy:**

We are pleased with the strong performance of our key products, which continues to drive growth in our net revenue. We remain committed to our strategic priorities, including investment in research and development and expansion into new markets.

**Shareholder Value Creation:**

Our focus on improving shareholder value is unwavering. With a projected Return on Equity (ROE) of 20% for the full year FY24, we are confident that our initiatives will drive long-term value creation for our shareholders.

Please note that this report is confidential and should not be shared with any external parties without explicit permission from management.